PMID: 6356861Nov 1, 1983Paper

Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy

The American Journal of Cardiology
B MaischK Kochsiek


Circulating muscle-specific antimyolemmal antibodies (AMLAs) were found in 18 of 61 patients with secondary dilated cardiomyopathy (DC). All 18 patients had clinical or histologic evidence of previous perimyocarditis. AMLAs were found both in patients' serum samples and bound to the sarcolemmal sheath of the autologous myocardial biopsy specimen. Only AMLAs in postmyocardiac DC induced cytolysis of vital cardiocytes in the presence of complement, whereas hepatocytes remained unaffected. Titers of AMLAs correlated with the degree of cardiocytolysis. In contrast, antiinterfibrillary antibodies were found in 49% patients with primary DC (n = 79) and in 61% of patients (n = 30) with alcoholic DC. The incidence of antifibrillary antibodies of the antimyosin type was 23 and 24%, respectively. Incidence of both antibodies increased according to the severity assessed by New York Heart Association functional classes. Circulating immune complexes assayed by a new Clq-solid phase fluorometric assay were present in 30% of patients with postmyocarditic DC only. Lymphocyte-mediated cytotoxicity against heterologous cardiac target cells (K-cell activity) was measured in 33% of patients each with primary and secondary alcoholic DC but not post...Continue Reading


Sep 18, 1975·The New England Journal of Medicine·C Kawai, T Takatsu
Jun 1, 1979·British Heart Journal·G CambridgeC M Oakley
Aug 1, 1977·The Journal of Experimental Medicine·L C YangE N Fox
May 16, 1975·Deutsche medizinische Wochenschrift·P A BergH Brügel
Nov 1, 1973·American Heart Journal·A B KirsnerN O Fowler
Dec 15, 1967·Experientia·G E BurchN P De Pasquale
May 1, 1969·American Heart Journal·T F CampN O Fowler
Mar 3, 1980·Klinische Wochenschrift·B MaischK Kochsiek

❮ Previous
Next ❯


Feb 1, 1990·Clinical Cardiology·S S Maze, R J Adolph
Sep 1, 1995·Clinical Cardiology·A M FeldmanS Murali
Feb 17, 1993·Molecular and Cellular Biochemistry·T IzumiM Kodama
Jan 1, 1985·Heart and Vessels. Supplement·B Maisch, T Izumi
Jan 1, 1985·Heart and Vessels. Supplement·S K DasS A Huber
Jan 1, 1989·Immunologic Research·L J Wolfgram, N R Rose
Jun 1, 1988·American Heart Journal·T ItagakiR Kusukawa
Feb 28, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·O Oster
Jun 1, 1990·Journal of the American College of Cardiology·A L CaforioW J McKenna
Dec 1, 1991·Journal of the American College of Cardiology·E B LiebermanK L Baughman
Aug 1, 1991·Journal of the American College of Cardiology·T H TahaC M Oakley
Nov 1, 1993·Journal of the American College of Cardiology·A HerskowitzA A Ansari
Jul 1, 1992·Trends in Cardiovascular Medicine·L G Lange, G F Schreiner
Apr 1, 1995·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·M KodamaN Higuma
Mar 26, 2002·International Journal of Cardiology·Vicens MartíJosep M Augé
Nov 1, 1990·Journal of the American College of Cardiology·D A NeumannA Herskowitz
Jun 1, 1987·Journal of the American College of Cardiology·A HerskowitzK W Beisel
Apr 6, 2002·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Bernhard MaischSabine Pankuweit
Jul 9, 2002·Immunology·Vanessa S CullCassandra M James
Apr 21, 1994·The New England Journal of Medicine·L G Lange, G F Schreiner
Sep 7, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·C M Lawson, M W Beilharz
Jul 5, 2013·European Heart Journal·Alida L P CaforioUNKNOWN European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
May 1, 1993·European Journal of Clinical Investigation·A WaldenströmB Gerdin
Aug 1, 1993·Journal of Internal Medicine·M SamsonovY Belenkov
Apr 7, 1990·BMJ : British Medical Journal·A L CaforioW J McKenna
Nov 1, 1989·British Heart Journal·C J Limas, C Limas
Nov 30, 2007·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Mototsugu NishiiToru Izumi
Aug 9, 2002·European Journal of Heart Failure·Alida L P CaforioWilliam J McKenna
Dec 21, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·R Dalla PozzaH Netz
Nov 2, 2012·Heart Failure Reviews·Alida L P CaforioS Iliceto
Mar 5, 2016·Disease Markers·Konstantinos KaratoliosBernhard Maisch
Mar 23, 2007·Brain & Development·Tsuyoshi MatsumuraSusumu Shinno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.